Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock par value $0.001 per share
-
Shares outstanding
-
133,936,717
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
17,761,607
-
Shares change
-
+9,206,576
-
Total reported value, excl. options
-
$73,712,290
-
Value change
-
+$38,255,959
-
Number of buys
-
47
-
Number of sells
-
-9
-
Price
-
$4.15
Significant Holders of Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) as of Q4 2019
63 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock par value $0.001 per share as of Q4 2019.
Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,761,607 shares
of 133,936,717 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (2,888,888 shares), FMR LLC (2,084,900 shares), VANGUARD GROUP INC (1,488,529 shares), RENAISSANCE TECHNOLOGIES LLC (1,084,709 shares), AXA (867,602 shares), CHI Advisors LLC (843,931 shares), BVF INC/IL (734,301 shares), CITIGROUP INC (501,462 shares), WELLS FARGO & COMPANY/MN (473,633 shares), and BlackRock Inc. (450,746 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.